Castle Biosciences: Q2 Earnings Insights

Castle Biosciences CSTL reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Castle Biosciences missed estimated earnings by 1.32%, reporting an EPS of $-0.77 versus an estimate of $-0.76.

Revenue was up $12.08 million from the same period last year.

Last quarter the company missed on EPS by $0.26 which was followed by a 5.79% increase in the share price the next day.

Here's a look at Castle Biosciences's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.71	-0.47	-0.40	-0.37
EPS Actual	-0.97	-0.25	-0.47	-0.34
Revenue Estimate	25.21M	23.74M	22.97M	18.93M
Revenue Actual	26.85M	25.04M	23.48M	22.76M

To track all earnings releases for Castle Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar